Loading
Yanuki
ARTICLE DETAIL
Medical Tech Leader Venus Concept Announces Q1 2025 Earnings Date | Old National and Indiana Fever Team Up to Assist Small Businesses | Spirit Airlines Liquidation: What Happens to Its Planes? | Spirit Airlines' Crowdsourced Revival Attempt | Strauss Zelnick: The Unlikely CEO Behind Grand Theft Auto's Success | Shaquille O'Neal Oversees Reebok Resurgence Amid Nike's Struggles | Fidelity Reorganizes Teams with Job Cuts and New Hires | Gas Prices Surge Amid Iran War: Why You're Paying More at the Pump | Pressure Mounts on California Attorney General to Scrutinize Paramount-Warner Bros. Discovery Merger | Medical Tech Leader Venus Concept Announces Q1 2025 Earnings Date | Old National and Indiana Fever Team Up to Assist Small Businesses | Spirit Airlines Liquidation: What Happens to Its Planes? | Spirit Airlines' Crowdsourced Revival Attempt | Strauss Zelnick: The Unlikely CEO Behind Grand Theft Auto's Success | Shaquille O'Neal Oversees Reebok Resurgence Amid Nike's Struggles | Fidelity Reorganizes Teams with Job Cuts and New Hires | Gas Prices Surge Amid Iran War: Why You're Paying More at the Pump | Pressure Mounts on California Attorney General to Scrutinize Paramount-Warner Bros. Discovery Merger

Business / Earnings Reports

Medical Tech Leader Venus Concept Announces Q1 2025 Earnings Date

Venus Concept Inc. (NASDAQ: VERO), a prominent global player in the medical aesthetic technology sector, has scheduled the release of its financial results for the first quarter of the fiscal year 2025. This announcement is keenly watched b...

Share
X LinkedIn

Medical Tech Leader Venus Concept Announces Q1 2025 Earnings Date

Key Insights

  • **What:** Release of Q1 Fiscal Year 2025 Financial Results.
  • **Who:** Venus Concept Inc. (NASDAQ: VERO).
  • **When:** Tuesday, May 14, 2024, after the market closes (approximately 5:00 p.m. ET).
  • **Details:** Results will be followed by a conference call and live webcast for discussion.
  • **Why this matters:** Earnings reports provide crucial insights into a company's financial health, operational performance, and future outlook. For Venus Concept, this reveals its standing in the competitive medical aesthetics market and can influence its stock performance.

In-Depth Analysis

Based in Toronto, Canada, Venus Concept develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies. Their upcoming earnings call is a standard corporate practice that offers transparency to shareholders and the financial community.

Investors and analysts will scrutinize revenue growth, profit margins, and any forward-looking guidance provided by management during the call. The performance detailed in this report reflects the company's recent operational success and market adaptation.

**How to Prepare:** Interested parties should mark their calendars for May 14th after market close. Access details for the webcast and conference call dial-in numbers are available in the official press release (see Sources).

**Who This Affects Most:** - Current shareholders of VERO. - Potential investors considering a position in the company. - Financial analysts covering the medical technology and aesthetics sectors. - Competitors within the medical aesthetics industry.

Read source article

FAQ

- **Q: When will Venus Concept announce its Q1 2025 earnings?

**

- **Q: How can I listen to the earnings conference call?

**

Takeaways

  • Mark your calendar: Venus Concept's Q1 2025 earnings are out May 14, 2024 (post-market close).
  • This report is a key indicator of the company's financial health and position in the medical aesthetics market.
  • Access the results and discussion via the company's official webcast or conference call.

Discussion

Do you follow Venus Concept stock or developments in the medical aesthetics industry? Let us know your thoughts!

*Share this article with others who need to stay ahead of this trend!*

Sources

Source 1: Venus Concept to Release First Quarter of Fiscal Year 2025 Financial Results - Stocktitan

Disclaimer

This article was compiled by Yanuki using publicly available data and trending information. The content may summarize or reference third-party sources that have not been independently verified. While we aim to provide timely and accurate insights, the information presented may be incomplete or outdated.

All content is provided for general informational purposes only and does not constitute financial, legal, or professional advice. Yanuki makes no representations or warranties regarding the reliability or completeness of the information.

This article may include links to external sources for further context. These links are provided for convenience only and do not imply endorsement.

Always do your own research (DYOR) before making any decisions based on the information presented.